Petrus Trust Company, Lta Pulmonx Corp Transaction History

Petrus Trust Company, Lta

  • $949 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.77 - $9.82 $317,263 - $539,952
54,985 Added 243.17%
77,597 $491,000
Q1 2024

May 15, 2024
SELL
$8.71 - $14.65 $53,165 - $89,423
-6,104 Reduced 21.26%
22,612 $209,000
Q4 2023

Feb 14, 2024
BUY
$7.89 - $13.14 $226,569 - $377,328
28,716 New
28,716 $366,000

Others Institutions Holding LUNG

# of Institutions
123
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email